Béa Fertility has developed a clinical-grade at-home fertility kit that enables users to perform Intracervical Insemination (ICI) safely at home using a small cervical cap and a clinically approved applicator. The cap is left in place for an hour, requires no invasive hormone injections or clinical procedures, and can be used with donor semen. The company’s first treatment is available to purchase online and is intended for early adopters in the UK. Béa is also launching a pilot to trial the Béa Treatment Kit within the NHS in partnership with South Fulham Primary Care Network to provide direct access to fertility treatment in primary care. Leadership includes femtech expert Tess Cosad and product engineer George Thomas. Financially, the company raised $3.2m in the reported round, bringing total funding to date to $4.2m.

Total raised

$3M

Funding rounds

1

Latest round

Equity

Latest activity

Jul 2023